Aztreonam Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-401

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Aztreonam (NDC 63323-401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Azt02 0001 01

Chemical structure diagram of Aztreonam, showing its molecular arrangement with identifiable functional groups and bonds corresponding to the antibiotic Aztreonam.*

FDA Label Image

Azt02 0001 02

A line graph titled Figure 1 depicting Aztreonam serum concentration (mcg/mL) over time (hours) following intramuscular (IM) and intravenous (IV) administration of 500 mg, 1 g, and 2 g doses. The graph shows declining serum concentrations for each route and dose over an 8-hour time period.*

FDA Label Image

Azt02 0001 03

FDA Label Image

Azt02 0001 04

Label for Aztreonam 1 gram per vial injection powder, lyophilized, for intravenous or intramuscular use. Single-dose vial with 1 g dosage, made by Fresenius Kabi USA, LLC, Lake Zurich, IL. The label includes storage instructions, identifying that the vial contains approximately 780 mg arginine and sodium-free formulation.*

FDA Label Image

Azt02 0001 05

Aztreonam 1 gram injection powder, lyophilized, for solution vial label. The label specifies 1 gram per vial for intravenous or intramuscular use after constitution. Packaging contains 10 single-dose vials of 20 mL each. Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, IL. Storage instructions and product composition details are included.*

FDA Label Image

Azt02 0001 06

Aztreonam for Injection, USP 2 grams per vial, powder, lyophilized for solution. Single-dose vial labeled for intravenous or intramuscular use after constitution. Manufactured by Fresenius Kabi USA, LLC. Storage instructions and additional product information are included on the label.*

FDA Label Image

Azt02 0001 07

Aztreonam for Injection, USP 2 grams per vial lyophilized powder for solution. For intravenous or intramuscular use after constitution. Pack includes 10 single-dose vials of 30 mL each. Manufactured by Fresenius Kabi USA, LLC. Storage instructions and NDC code are shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.